Stay updated with breaking news from Nasdaq Aclx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Arcellx, Inc. (NASDAQ:ACLX – Get Free Report) shares were down 4.4% during trading on Tuesday . The stock traded as low as $49.37 and last traded at $50.89. Approximately 363,629 shares changed hands during mid-day trading, a decline of 32% from the average daily volume of 533,040 shares. The stock had previously closed at $53.21. […]
Arcellx (NASDAQ:ACLX – Get Free Report) and Protalix BioTherapeutics (NYSE:PLX – Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, dividends, risk, profitability, analyst recommendations and institutional ownership. Analyst Recommendations This is a breakdown of recent recommendations […]
Arcellx, Inc. (NASDAQ:ACLX – Get Free Report)’s share price gapped up before the market opened on Thursday after Needham & Company LLC raised their price target on the stock from $51.00 to $60.00. The stock had previously closed at $49.99, but opened at $51.41. Needham & Company LLC currently has a buy rating on the […]
Arcellx, Inc. (NASDAQ:ACLX – Get Free Report) has been given a consensus recommendation of “Buy” by the twelve analysts that are covering the stock, Marketbeat reports. Twelve analysts have rated the stock with a buy recommendation. The average 12 month target price among brokers that have covered the stock in the last year is $53.31. […]
TD Cowen assumed coverage on shares of Arcellx (NASDAQ:ACLX – Free Report) in a report released on Monday, Marketbeat Ratings reports. The brokerage issued an outperform rating on the stock. Several other equities analysts have also recently commented on the company. Robert W. Baird boosted their target price on Arcellx from $40.00 to $52.00 and […]